The Role of Community Pharmacists in Increasing Patients' Drug Compliance

Yıl 2022, Cilt: 47 Sayı: 3, 339 - 346, 19.10.2022

Felat Çelebi Muammer Çalıkuşu , Gülbin Özçelikay

https://doi.org/10.55262/fabadeczacilik.1092310

Cited By: 1

Öz

In this study, the importance of compliance to treatment for the patient to benefit from the treatment, and the effects of patient compliance were determined. The study is a decisive type of research. The forms with 5-point Likert-type questions created by the researchers were asked to community pharmacists via the Internet. 110 pharmacists from different parts of Turkey participated in the survey. The data obtained in the research were analyzed with the SPSS ver. 25.0 program. The significance level (α) was determined as 0.05 in the analyzes made in the study. The Cronbach-alpha reliability coefficient for the developed scale was found to be 0.847. In this study, it is found that community pharmacists make an effort to increase the drug compliance of patients. There was no significant difference between the age and professional experience of the pharmacist in improving patient compliance. Pharmacists need to work more systematically to improve patients' drug compliance. It is thought that the concept of drug compliance is frequently included in the education curriculum of Pharmacy Schools. Still, the necessary educational content and learning opportunities are not sufficient to increase it.

Anahtar Kelimeler

compliance, drug compliance, community pharmacy, pharmacist

Hastaların İlaç Uyumunun Arttırılmasında Toplum Eczacılarının Rolü

Öz

Bu çalışmada, hastanın tedaviden yarar görmesi için tedaviye uyumunun önemi ve hasta uyumunun nelerden etkilendiği belirlenmiştir. Çalışma, betimleyici tiptedir. Araştırmacılar tarafından oluşturulan 5’li lkert tipi soruların bulunduğu formlar, anket tekniği ile toplum eczacılarına internet ortamında uygulanmıştır. Ankete Ankara'nın farklı yerlerinden 110 eczacı katılmıştır. Araştırmada elde edilen veriler SPSS ver. 25.0 programı kullanılarak analiz edilmiştir. Araştırmada yapılan analizlerde anlamlılık düzeyi (α) 0,05 olarak belirlenmiştir. Geliştirilen ölçek için Cronbach-alpha güvenirlik katsayısı 0,847 olarak bulunmuştur. Bu çalışmada, toplum eczacılarının hastaların ilaç uyumunu artırmak için çaba sarf ettikleri görülmektedir. Hasta uyumunu arttırmada eczacının yaş ve mesleki deneyimi arasında anlamlı bir fark görülmemiştir. Eczacıların hastaların ilaç uyumunu artırmak için daha sistemli çalışması gerekmektedir. Eczacılık Fakültesi eğitim müfredatında ilaç uyumu kavramının sıklıkla yer aldığı ancak arttırmak için gerekli eğitim içeriği ve öğrenme fırsatlarının yeterli olmadığı düşünülmektedir.

Anahtar Kelimeler

uyum, ilaç uyumu, toplum eczacılığı, eczacı

Kaynakça

• Büyüköztürk, Ş., Kılıç Çakmak, E., Akgün, Ö. E., Karadeniz Oran, Ş., Demirel, F. (2019). Bilimsel araştırma yöntemleri. Ankara: Pegem Akademi.
• Colom, F., Vieta, E., Martínez-Arán, A., Reinares, M., Goikolea, J.M., Benabarre, A., Torrent, C., Comes, M., Corbella, B., Parramon, G., Corominas, J. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60(4), 402-407. doi: 10.1001/archpsyc.60.4.402
• Çalıkuşu, M., Güneş, G., Özçelikay, G. (2021). Covid-19 pandemisinin toplum eczacılığı hizmetlerine etkileri. Journal of Faculty of Pharmacy of Ankara University, 45(2), 194-211. doi:10.33483/jfpau.831105
• Darbishire, P.L., Mashrah, D. (2018). Comparison of student and patient perceptions for medication non-adherence. American Journal of Pharmaceutical Education, 82(9), 6444. doi: 10.5688/ajpe6444
• DirectRx Pharmacy (2020), Launches new operating system to ıncrease compliance and engagement between patients and providers. https://www.globenewswire.com/news-release/2020/08/13/2077738/0/en/DirectRx-Pharmacy-Launches-New-Operating-System-to-Increase-Compliance-and-Engagement-Between-Patients-and-Providers.html#:~:text=13%2C%202020%20(GLOBE%20NEWSWIRE),mission%20to%20increase%20compliance%20among, Access Date: March 2022.
• Fallowfield, L. (2009). The clinical importance of patient adherence to therapy. Advances in Breast Cancer, 6(2), 9-12.
• Giannetti, V.J., Kamal, K.M. (2016). Adherence with therapeutic regimens: Behavioral and pharmacoeconomic perspectives. Journal of Pharmacy Practice, 29(2), 138-143. doi:10.1177/0897190014549840
• Goggin, K., Hawes, S.M., Duval, E.R., Spresser, C.D., Martínez, D.A., Lynam, I., Barnes, A., Hinton-Dampf, A.M., Murphy, M.E., Marken, P.A., Catley. D. (2010). A motivational interviewing course for pharmacy students. American Journal of Pharmaceutical Education, 74(4), 70. doi:10.5688/aj740470
• Hughes, D., Cowell, W., Koncz, T., Cramer, J. (2007). Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations. Value in Health, 10(6), 498-509. doi: 10.1111/j.1524-4733.2007.00205.x
• Jimmy, B., Jose, J. (2011). Patient medication adherence: Measures in daily practice. Oman Medical Journal, 26(3), 155-159. doi: 10.5001/omj.2011.38
• Kadambi, A., Leipold, R.J., Kansal, A.R., Sorensen, S., Getsios, D. (2012). Inclusion of compliance and persistence in economic models. Applied Health Economics and Health Policy, 10(6), 365-379. doi: 10.1007/bf03261872
• Kardas, P., Lewek, P., Matyjaszczyk, M. (2013). Determinants of patient adherence: A review of systematic reviews. Frontiers in Pharmacology, 4, 91. doi: 10.3389/fphar.2013.00091
• Khalil, V., Blackley, S., Subramaniam, A. (2021). Evaluation of a pharmacist-led shared decision-making in atrial fibrillation and patients’ satisfaction—a before and after pilot study. Irish Journal of Medical Science, 190(2), 819-824. doi: 10.1007/s11845-020-02343-y
• Krummenacher, I., Cavassini, M., Bugnon, O., Schneider, M.P. (2011). An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care, 23(5), 550-561. doi: 10.1080/09540121.2010.525613
• López Cabezas, C., Falces Salvador, C., Cubí Quadrada, D., Arnau Bartés, A., Ylla Boré, M., Muro Perea, N., Homs Peıpoch, E. (2006). Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farmacia Hospitalaria, 30(6), 328-342. doi: 10.1016/s1130-6343(06)74004-1
• Nasseh, K., Frazee, S.G., Visaria, J., Vlahiotis, A., Tian, Y. (2012). Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. The American Journal of Pharmacy Benefits, 4(2), e41-e47.
• Pehlivanlı, A., Akyol, B., Demirel, Ö., Göçün, Ö., Onay Beşikçi, A., Özçelikay, A.T., Özçelikay, G. (2021). The role of the pharmacist in hypertension management: A model applicatıon in primary health care. Journal of Faculty of Pharmacy of Ankara University, 45(1), 1-11. doi:10.33483/jfpau.809585
• Savaş, M. (2020). Kanser hastalarının opioid analjezik kullanımına ilişkin görüşlerinin değerlendirilmesi ve hasta eğitiminde klinik eczacının rolü (Master's thesis).
• Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43(6), 521-530. doi: 10.1097/01.mlr.0000163641.86870.af
• Spencer, K.L. (2018). Transforming patient compliance research in an era of biomedicalization. Journal of Health and Social Behavior, 59(2), 170-184. doi: 10.1177/0022146518756860
• Su, K.-P., Lu, N., Tange, C.-H., Chiu, W.-C., Chang, H.-C., Huange, K.-C. (2019). Comparisons of the risk of medication noncompliance and suicidal behavior among patients with depressive disorders using different monotherapy antidepressants in Taiwan: A nationwide population-based retrospective cohort study. Journal of Affective Disorders, 250, 170-177. doi: 10.1016/j.jad.2019.03.039
• Toklu, H.Z. (2015). Eczacılık uygulamalarında akılcı ilaç kullanımı. Türkiye Klinikleri J Pharmacol-Special Topics, 3(1), 74-83.
• Toklu, H.Z., Akıcı, A., Uysal, M.K., Dülger, G.A. (2010). Akılcı ilaç kullanımı sürecinde hasta uyuncuna hekim ve eczacının katkısı. Türkiye Aile Hekimliği Dergisi, 14(3), 139-145. doi:10.2399/tahd.10.139
• Ulmer, R. A. (1977). Compliance with therapeutic regimens. In: D.L. Sackett, & R.B. Haynes (Eds.), Behavior Therapy (pp.1017-1019). Baltimore, United States of America: The Johns Hopkins University Press.
• Vrijens, B., Geest, S.D., Hughes, D.A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., Matyjaszczyk, M., Mshelia, C., Clyne, W., Aronson, J.K., Urquhart, J. (2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73(5), 691-705. doi: 10.1111/j.1365-2125.2012.04167.x
• Willoughby, R.R. (1932). Some properties of the Thurstone Personality Schedule and a suggested revision. The Journal of Social Psychology, 3(4), 401-424. doi: 10.1080/00224545.1932.9919168